Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Sunday 22 August 2021 12:01 am  |  Updated:  Friday 05 November 2021 6:07 pm

National Covid-19 antibody surveillance programme launched by government

By: Farah Ghouri

Add as a preferred source on Google
Sodexo has become the latest service provider to have its contract to run test and trace facilities for the NHS extended.
The government is working closely with the NHS to make it as easy as possible to get a vaccine, including through ‘grab a jab’ pop-up vaccine sites across the country, such as London-based nightclub Heaven, as well as football stadiums and festivals up and down the country.

A nation-wide antibody surveillance programme for the public has been launched by the UK Health Security Agency to collect data to build the government’s understanding of immunity against Covid-19.

The government today announced that free home antibody tests kits will be offered to adults in the UK who test positive for the virus from Tuesday.

Anyone over 18 years old will have the chance to opt in to take part in the programme when booking a PCR test through the NHS Test and Trace system.

The government said up to 8,000 people out of those who opt in and get a positive PCR result, will then be sent two finger prick antibody tests which they can use at home before sending back to a lab for analysis.

The UK Health Security Agency plans to use the data collected to help estimate the proportion of people who got Covid-19 despite developing antibodies after either having a vaccine or previously catching the virus. They said the programme could also contribute to insight about any groups of people who do not develop an immune response.

Sajid Javid, the secretary of state for health and social care, said: “Our new national antibody testing will be quick and easy to take part in, and by doing so you’ll be helping strengthen our understanding of COVID-19 as we cautiously return to a more normal life.”

He added that the UK vaccination programme has already prevented “around 24 million infections and more than 100,000 deaths in England alone. I urge everyone across the UK to get both vaccinations as soon as possible.”

Dr Jenny Harries, the chief executive of the UK National Health Security Agency said antibody testing was being rolled out across the UK “to gain vital data into the impact of our vaccination programme and on immune responses to different variants of Covid-19.”

“The best way to protect yourself and those around you is by getting vaccinated,” she added, “I encourage anyone who has not yet come forward to book their first and second jabs.” 

Commenting on the UK’s testing progress, Dr Susan Hopkins, the Covid-19 strategic response director of Public Health England, said:  “Our testing armoury is stronger than ever now we are rolling out antibody testing to thousands of people in England, Scotland, Wales and Northern Ireland alongside the vast testing capacity we have built including our NHS Test and Trace system.  

Read more

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • Coronavirus
  • Healthtech
  • NHS
  • Pharmaceuticals
  • Test and Trace
  • Vaccine

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • A meeting with the breakfast king of Mayfair

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • FTSE 100 Live: Stocks jump on defence and metals boost; Oil on track to shed a fifth on US-Iran peace hopes

  • BT tops FTSE 100 after finding new home for international business with Verizon joint venture

More from City PM

  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

    Business Wire
  • Bank of England’s Bailey defends bond sale programme

    Economics
    Governor Andrew Bailey has launched a defence of the Federal Reserve's independence.
  • Adobe and LinkedIn target AI skills gap in marketing roles

    Tech
    Office for National Statistics
  • Liz Kendall hails ‘Brit-maxxing’ as Labour bets £1.1bn on AI chip race

    Tech
    Work and Pensions Secretary Liz Kendall is in charge of reforming the state pension and benefits system
  • Babcock predicts global government defence spending spree after hit to profit

    Investing
    Babcock is a member of the FTSE 100.
  • Starmer’s social media restrictions will mean the government can spy on every phone

    Opinion
    Keir Starmer at tech event discussing innovation and policy, surrounded by tech leaders and digital displays
  • Starmer: Britain must ‘not stick its head in the sand’ on AI

    Tech
    Starmer is set to reshuffle his top team.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy